142 related articles for article (PubMed ID: 7905252)
21. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
[TBL] [Abstract][Full Text] [Related]
22. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
23. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
[TBL] [Abstract][Full Text] [Related]
24. Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone).
Weber JM; Sircar S; Horvath J; Dion P
Cancer Res; 1989 Nov; 49(21):5779-83. PubMed ID: 2571411
[TBL] [Abstract][Full Text] [Related]
25. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
26. alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine A.
Greenberger LM; Collins KI; Annable T; Boni JP; May MK; Lai FM; Kramer R; Citeralla RV; Hallett WA; Powell D
Oncol Res; 1996; 8(5):207-18. PubMed ID: 8884813
[TBL] [Abstract][Full Text] [Related]
27. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
[TBL] [Abstract][Full Text] [Related]
28. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
29. Suramin inhibits the growth of human breast cancer cell lines. Studies on parental lines and corresponding sublines with acquired doxorubicin resistance with and without expression of P-glycoprotein.
Lindman H; Taube A; Bergh JC
Anticancer Res; 1994; 14(2A):363-6. PubMed ID: 7912491
[TBL] [Abstract][Full Text] [Related]
30. Activity of different revertant agents on multidrug resistance: in vitro evaluation of their combination.
Petrini M; Mattii L; Sabbatini AR; Conte A; Grassi B; Ronca G
Int J Tissue React; 1993; 15(1):17-23. PubMed ID: 7904261
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases.
Peters WH; Roelofs HM
Cancer Res; 1992 Apr; 52(7):1886-90. PubMed ID: 1348015
[TBL] [Abstract][Full Text] [Related]
32. Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells.
Pannocchia A; Revelli S; Tamponi G; Giorgianni A; Todde R; Bosia A; Ghigo D
Cell Biochem Funct; 1996 Mar; 14(1):11-8. PubMed ID: 8907249
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T
Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140
[TBL] [Abstract][Full Text] [Related]
34. The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro.
Ziv Y; Gupta MK; Milsom JW; Vladisavljevic A; Brand M; Fazio VW
Anticancer Res; 1994; 14(5A):2005-9. PubMed ID: 7847841
[TBL] [Abstract][Full Text] [Related]
35. Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles.
Garrigos M; Belehradek J; Mir LM; Orlowski S
Biochem Biophys Res Commun; 1993 Nov; 196(3):1034-41. PubMed ID: 7902705
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic instability of drug sensitivity in a human colon carcinoma cell line.
Ferguson PJ; Cheng YC
Cancer Res; 1989 Mar; 49(5):1148-53. PubMed ID: 2563672
[TBL] [Abstract][Full Text] [Related]
37. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
Page RL; Hughes CS; Huyan S; Sagris J; Trogdon M
Anticancer Res; 2000; 20(5B):3533-8. PubMed ID: 11131658
[TBL] [Abstract][Full Text] [Related]
38. Toremifene resistance in a rat mammary tumour model.
Kellen JA; Georges E; Ling V; Dubsky M
Anticancer Res; 1992; 12(5):1663-5. PubMed ID: 1359832
[TBL] [Abstract][Full Text] [Related]
39. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
[TBL] [Abstract][Full Text] [Related]
40. The induction of multidrug resistance in human cervical carcinoma cell lines by estrogenic hormones.
Biing JT; Yang YF; Liu HS; Ye CT; Chao CF
Proc Natl Sci Counc Repub China B; 1994 Apr; 18(2):64-70. PubMed ID: 7915038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
